AIM
BHVN

Aigen Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Aigen Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,414
Closed -$250K – 1240
2021
Q4 		$250K Buy
+2,414
New +$250K 0.02% 857
2021
Q2 		– Sell
-3,033
Closed -$207K – 819
2021
Q1 		$207K Buy
+3,033
New +$207K 0.03% 536